Citations

Showing 10 of 108083 citations.

The Association Between Preoperative International Normalized Ratio Values and Postoperative Outcomes including Mortality in Geriatric Femoral Neck Fractures Treated With Hemiarthroplasty
Uvodich, Mason E. , Dugdale, Evan M. , Duong, Stephanie Q. , Cancio-Bello, Alexandra , Sems, S.A. , Yuan, Brandon J. , Yuan, Brandon

Mayo Clinic

Journal of Orthopaedic Trauma | February 2, 2023 | Volume: 37 | Issue: 5 | Pages: 230-236

10.1097/bot.0000000000002557 | PMID 36728865 Get It

Objectives: To evaluate the association between preoperative international normalized ratio (INR) and postoperative mortality and other outcomes after hemiarthroplasty for geriatric femoral neck fractures. Design: Retrospective cohort study. Setting: A single Level-I trauma center. Patients/Participants: Patients ≥55 years of age with OTA/AO 31B proximal femur fractures [1556 patients (1616 hips)] Intervention: Hip hemiarthroplasty. Main Outcome Measurements: Ninety-day mortality, postoperative transfusion within 72 hours, and 90-day postoperative outcomes. Results: Adjusting for confounders, the association of preoperative INR and 90-day mortality was not statistically significant [hazard ratio (HR): 1.3; 95% confidence interval (CI): 0.97, 1.8; P = 0.08]. Dementia (HR: 1.9; 95% CI: 1.4–2.6; P < 0.001), Charlson Comorbidity Index (HR: 1.1; 95% CI: 1.1–1.2; P < 0.001), and age by decade (HR: 1.4; 95% CI: 1.1–1.8; P = 0.002) were associated with 90-day mortality. Increasing INR was significantly associated with blood transfusion [odds ratio (OR) 1.4; 95% CI 1.03–1.6; P = 0.031]. Preoperative hemoglobin <10 g/dL (OR 13.7; 95% CI 8.4–23.3; P < 0.001) was also associated with a postoperative transfusion, whereas intraoperative tranexamic acid use (OR 0.3; 95% CI 0.2–0.5; P < 0.001) was inversely associated with postoperative transfusion rate. INR was associated with superficial wound infection (HR: 2.0; 95% CI: 1.1–3.7; P = 0.02) and noninfected wound complications (HR: 1.6; 95% CI: 1.1–2.4; P = 0.007). Risk of superficial infection increased when INR was >1.8. Conclusion: When controlling for confounders, preoperative INR was not significantly associated with 90-day mortality. Underlying medical conditions contribute to postoperative mortality more than an elevated INR. However, INR is associated with superficial wound complications. This risk becomes statistically significant as INR rises above 1.8. Level of Evidence: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.
Coronavirus Disease 2019 in Pediatric Oncology Patients: A Matched–Cohort Analysis of the SCCM Discovery Viral Infection and Respiratory Illness Universal Study COVID-19 Registry
Balakumar, Niveditha , Nadiger, Meghana , Keshavamurthy, Prithvi Raj Sendi, Totapally, Balagangadhar , Sherani, Farha, Mba, Nkechi, Kumar, Vishakha K. , Bhalala, Utpal , Catueno, Samanta , Gist, Katja M. , Tripathi, Sandeep , Gajic, Ognjen , Deo, Neha , Walkey, Allan J. , Kashyap, Rahul

Mayo Clinic

Journal of Pediatric Hematology/Oncology | February 2, 2023 | Volume: 45 | Issue: 3 | Pages: e309-e314

10.1097/mph.0000000000002588 | PMID 36729758 Get It

Background: There is a paucity of multicenter data describing the impact of coronavirus disease 2019 (COVID-19) on hospitalized pediatric oncology patients. Using a large, multicenter, Society of Critical Care Medicine (SCCM) Discovery Viral Infection and Respiratory Illness University Study (VIRUS) database, we aimed at assessing outcomes of COVID-19 infection in this population. Method: This is a matched-cohort study involving children below 18 years of age hospitalized with COVID-19 between March 2020 and January 2021. Using the VIRUS; COVID-19 Registry database, children with oncologic diseases were compared with propensity score matched (age groups, sex, race, and ethnicity) cohort of children without oncologic diseases for the prevalence of Multisystem Inflammatory Syndrome in Children (MIS-C), intensive care unit (ICU) admission, interventions, hospital, and ICU length of stay. Results: The number of children in the case and control groups was 45 and 180, respectively. ICU admission rate was similar in both groups ([47.7 vs 51.7%], P=0.63). The proportion of children requiring noninvasive and invasive mechanical ventilation, and its duration were similar between groups, same as hospital mortality. Interestingly, MIS-C was significantly lower in the oncology group compared with the control (2.4 vs 24.6%; P=0.0002). Conclusions: In this study using a multicenter VIRUS database, ICU admission rate, interventions, and outcomes of COVID-19 were similar in children with the oncologic disease compared with control patients. The incidence of MIS-C is lower in oncologic patients.
BRAF Immunohistochemical Studies of Pediatric Conjunctival Lesions
Chen, Kelsey , McInnis‐Smith, Kerri , Tiwari, Nishant , Moser, Justin C. , Ramasubramanian, Aparna

Mayo Clinic

Cornea | February 2, 2023 | Volume: 42 | Issue: 11 | Pages: 1404-1407

10.1097/ico.0000000000003196 | PMID 36729648 Get It

Purpose: The purpose of this study was to analyze the prevalence of an activating mutation in the B-Raf proto-oncogene (BRAF) V600E immunoreactivity in pediatric conjunctival lesions. Methods: This retrospective case–control study included 32 pediatric patients who underwent surgical excision of conjunctival lesions between Jan 2019 and May 2022. The collected data included demographic data, clinical features, and histopathologic characteristics of the lesion, including BRAF V600E positivity. The Student t test and the Fisher exact test were used to determine the significance of the associations between clinical variables and BRAF positivity. Results: BRAF immunoreactivity was positive in 11/32 lesions (34%). Age at diagnosis did not correlate with BRAF positivity, with a mean age at diagnosis of 131.7 months for patients with BRAF+ lesions and 134.7 months for those with BRAF− lesions (P > 0.1). No clinical or pathological features were found to be significantly correlated with BRAF positivity, although there was a trend toward BRAF positivity in the presence of cysts (P = 0.072). Conclusions: BRAF reactivity was present in approximately one-third of pediatric conjunctival nevi but does not correlate significantly with unique clinical or histopathological features.
CGRP, Migraine, and Brain MRI in CADASIL
Goldstein, Eric , Gopal, Neethu , Hodge, David O. , Glover, Patrick , Durham, Paul L. , Huang, Josephine F. , Baradaran, Hediyeh , Goldstein, Eric D , Badi, Mohammed K. , Havenon, Adam de , Lin, Michelle , Majersik, Jennifer Juhl , Meschia, James F.

Mayo Clinic

The Neurologist | February 2, 2023 | Volume: 28 | Issue: 4 | Pages: 231-236

10.1097/nrl.0000000000000478 | PMID 36729391 Get It

Background: Migraine is associated with neuroimaging differences in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). However, it is unknown if migraine-related disability (MRD) or if calcitonin gene-related peptide (CGRP), a vasoactive peptide important in migraine pathology, have radiographic implications. The aims of this study were to identify whether MRD or interictal serum CGRP levels impacted neuroimaging findings for those with CADASIL. Materials and Methods: A cross-sectional analysis was performed. The primary outcomes were neuroimaging differences associated with MRD among those with migraine or interictal serum CGRP levels of those with and without migraine. MRD was defined by 2 migraine disability scales (Migraine Disability Assessment, Headache Impact Test-6). Retrospective brain magnetic resonance imaging was reviewed (average 1.7 ± 2.0 y before enrollment). Rank-sum and χ2 tests were used. Results: Those with migraine (n=25, vs. n=14 without) were younger [median 49 (25 to 82) y vs. 60 (31 to 82) y, P<0.007], had fewer cerebral microbleeds (0 to 31 vs. 0 to 50, P=0.02) and less frequently had anterior temporal lobe T2 hyperintensities [68% (17/25) vs 100% (14/14), P=0.02]. MRD scale outcomes had no significant radiographic associations. Interictal serum CGRP did not differ (migraine: n=18, 27.0±9.6 pg/mL vs. no migraine: n=10, 26.8±15.7 pg/mL, P=0.965). Conclusions: Migraine may forestall microangiopathy in CADASIL, though possibly independent of severity as measured by MRD. Interictal serum CGRP did not differ in our cohort suggesting CGRP may not be vital to migraine pathophysiology in CADASIL. Larger studies are needed to account for age differences.
Factors Associated With Placebo Treatment Response in Functional Dyspepsia Clinical Trials
Jones, Michael , Guthrie-Lyons, Liam, Sato, Yuri , Jones, Michael P , Sato, Yuri A, Talley, Nicholas J.

Mayo Clinic

American Journal of Gastroenterology | February 2, 2023 | Volume: 118 | Issue: 4 | Pages: 685-691

10.14309/ajg.0000000000002097 | PMID 36729385 Get It

INTRODUCTION: Controlling for potential placebo effects is an important aspect of gaining an accurate estimate of how much the therapy alone changes patient symptoms or other end points. When the placebo effect is large, this can lead to only a small fraction of changes seen in the active therapy group being attributed to the therapy itself. This problem has been well studied in some disorders of brain-gut interaction but not in functional dyspepsia where placebo response rates of 40% and higher have been reported. Understanding risk factors for placebo response might lead to changes in trial design that could reduce the magnitude of the problem. This study sought to identify risk factors for the placebo effect in a functional dyspepsia clinical trial with a longer-term aim of suggesting trial design changes that might minimize the problem. METHODS: A secondary analysis of the clinical trial data was undertaken using 2 arms deemed to involve placebo therapy. Potential predictors were drawn from a wide range of patient characteristics including psychological, clinical, and physiological features. RESULTS: Predictors of a stronger placebo effect on the gastrointestinal symptom rating scale included higher functional dyspepsia symptom burden at baseline ( b = −0.101), coexisting irritable bowel syndrome ( b = −0.436), and higher scores on the Nepean Dyspepsia Index eat/drink domain (−0.005). Baseline symptom burden and coexisting irritable bowel syndrome were found to be independent placebo predictors, explaining 13% of the variance in change in gastrointestinal symptom rating scale. Anxiety, childhood sexual abuse, sleep amount, and frequent abdominal pain were also found to be predictors of change in individual symptom scores. DISCUSSION: The findings of this study yield actionable insights into trial methodology that may help to reduce the magnitude of the placebo effect in future functional dyspepsia treatment trials.
The fifth edition of the World Health Organization Classification and the International Consensus Classification of myeloid neoplasms: evolving guidelines in the molecular era with practical implications
Zheng, Gang , Li, Peng , Zhang, Xiaohui , Pan, Zenggang

Mayo Clinic

Current Opinion in Hematology | February 2, 2023 | Volume: 30 | Issue: 2 | Pages: 53-63

10.1097/moh.0000000000000748 | PMID 36728868 Get It

Purpose of review There have been major advances in our understanding of molecular pathogenesis of myeloid neoplasms, which prompt the updates in the classification of myeloid neoplasms in the fifth edition of World Health Organization Classification (WHO-5) and the new International Consensus Classification (ICC). The purpose of this review is to provide an overview of these two classification systems for myeloid neoplasms. Recent findings The definition, classification, and diagnostic criteria in many myeloid entities have been refined in WHO-5 and ICC with improved understanding of morphology and integration of new genetic findings. Particularly, molecular and cytogenetic studies have been increasingly incorporated into the classification, risk stratification, and selection of therapy of myeloid neoplasms. Overall, despite some revisions and discrepancies between WHO-5 and ICC, the major categories of myeloid neoplasms remain the same. Further validation studies are warranted to fine-tune and, ideally, integrate these two classifications. Summary Integration of clinical information, laboratory parameters, morphologic features, and cytogenetic and molecular studies is essential for the classification of myeloid neoplasms, as recommended by both WHO-5 and ICC.
Precision in Midfacial Volumization Using Ultrasound-Assisted Cannula Injections
Lowry, Natalia, Rohrich, Rod J., Swift, Arthur, Alfertshofer, Michael , Frank, Konstantin , Alfertshofer, Michael , Schelke, Leonie , Velthuis, Peter J. , Gotkin, Robert H. , Cotofana, Sebastian

Mayo Clinic

Plastic & Reconstructive Surgery | February 2, 2023 | Volume: 152 | Issue: 1 | Pages: 67-74

10.1097/prs.0000000000010131 | PMID 36728630 Get It

Background: Soft-tissue filler injections performed with a cannula are perceived to be less precise because of the length of the instrument and the blunt tip, which can deviate in any direction. Midfacial needle injections are favored despite the increased risk for intraarterial product placement. The objective of this study was to demonstrate that ultrasound-assisted cannula injections of the midface result in precise, safe, and effective volumization procedures. Methods: Midfacial injections with a 22-G cannula were performed in 188 midfaces of 94 healthy volunteers [86 women; age, 53.05 (9.9) years; 23.63 (2.1) kg/m2] under ultrasound-assisted guidance. Precision (ie, administration of product in the same plane as the location of the cannula tip), safety (ie, rate of adverse events), and aesthetic outcome (rated by the patient and the treating physician) were assessed. Results: In 100% of cases, the product was applied into the desired deep midfacial fat compartment, and the product did not migrate into more superficial layers during the injection process or at any follow-up visit. There was a statistically significant (P < 0.001) improvement in midfacial volume loss and the aesthetic outcome was rated as very much improved. No adverse events were reported throughout follow-up. Conclusions: Real-time imaging allows for visual feedback during cannula advancement and injection procedures in the midface and can help practitioners achieve safer aesthetic outcomes. It is hoped that practitioners decide to use a cannula more frequently for midfacial volumization, given the results presented in this article. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
Prevalence and Impact of Obesity in a Population-Based Cohort of Patients With Crohn’s Disease
Johnson, Amanda M. , Harmsen, William S. , Tremaine, William J., Raffals, Laura E. , Harmsen, William Scott, Aniwan, Satimai , Dayyeh, Barham K. Abu , Loftus, Edward V.

Mayo Clinic

Journal of Clinical Gastroenterology | February 2, 2023 | Volume: 58 | Issue: 2 | Pages: 176-182

10.1097/mcg.0000000000001821 | PMID 36728679 Get It

Background: Obesity is on the rise within the inflammatory bowel disease population. The impact obesity has on the natural history of Crohn’s disease (CD) is not well-understood. We aimed to describe the prevalence of obesity in a population-based cohort of newly diagnosed patients with CD, and the impact obesity had on disease phenotype and outcomes of corticosteroid use, hospitalization, intestinal resection, and development of fistulizing or penetrating disease. Materials and Methods: A chart review was performed on Olmsted County, Minnesota residents diagnosed with CD between 1970 and 2010. Data were collected on demographics, body mass index, CD location and behavior, CD-related hospitalizations, corticosteroid use, and intestinal resection. The proportion of individuals considered obese at the time of CD diagnosis was evaluated over time, and CD-associated complications were assessed with Kaplan-Meier survival analysis. Results: We identified 334 individuals diagnosed with CD between 1970 and 2010, of whom 156 (46.7%) were either overweight (27.8%) or obese (18.9%) at the time of diagnosis. The proportion of patients considered obese at the time of their diagnosis of CD increased 2-3 fold over the course of the study period. However, obesity did not have a significant impact on the future risk of corticosteroid use, hospitalization, intestinal resection, or development of penetrating and stricturing complications. Conclusions: Obesity is on the rise in patients with CD, although in this cohort, there did not appear to be any negative association with future CD-related outcomes. Further prospective studies, ideally including obesity measures such as visceral adipose tissue assessment, are warranted to understand the implications of the rising prevalence of obesity on CD outcomes.
Repair of an Extensive Defect of the Ear and Retroauricular Scalp
Shahwan, Kathryn T. , Demer, Addison M. , Maher, Ian A.

Mayo Clinic

Dermatologic Surgery | February 2, 2023 | Volume: 49 | Issue: 4 | Pages: 415-417

10.1097/dss.0000000000003626 | PMID 36729911 Get It

ROAR ED-SANE: A Retrospective Observational Assessment Review of an Emergency Department Sexual Assault Nurse Examiner Program's Adherence to Centers for Disease Control and Prevention Guidelines for Sexually Transmitted Infections
Nelson, Jennifer , Woolever, Nathan L. , Meyer, Lisa M, Hall, Scott, Stakston, Jaclyn , Dababneh, Ala S. , Roush, Kathleen , Sistine, Michael Van, Tempelis, Jennifer, Dierkhising, Ross , Lessard, Sarah , Nelson, Jennifer M, Woolever, Nathan, Meyer, Lisa, Dababneh, Ala, Van Sistine, Michael, Hall, Scott T.

Mayo Clinic

Sexually Transmitted Diseases | February 2, 2023 | Volume: 50 | Issue: 3 | Pages: 167-171

10.1097/olq.0000000000001745 | PMID 36729982 Get It

Background Sexual assault survivors are at increased risk for sexually transmitted infections. Sexual Assault Nurse Examiner programs guide sexually transmitted infection treatment, monitoring, and follow-up scheduling according to guidelines by the Centers for Disease Control and Prevention (CDC). Reported low rates of provider adherence to CDC treatment guidelines and patient adherence to follow-up necessitate a review of medication prescribing and follow-up scheduling practices, especially at smaller community hospitals in the United States. Methods A retrospective medical record review was conducted to assess adherence rates to CDC guidelines for prescribing practices, scheduling, and follow-up of sexual assault survivors. We included pediatric and adult patients presenting to the emergency department (ED) and participating in the ED Sexual Assault Nurse Examiner program at a rural, community-based teaching hospital in La Crosse, WI, from January 2018 to December 2021. Descriptive statistics were used to evaluate results. Results Analysis included 103 patients. Prescribing adherence to CDC guidelines was >80% for all except human immunodeficiency virus (53.4%), trichomoniasis (68.1%), and hepatitis B (69%). Of the 38 patients who had a follow-up scheduled during their ED encounter, 78.9% attended their scheduled follow-up and 94.7% of those appointments were scheduled within the CDC-recommended time frame, leading to an overall adherence of 40%. Conclusions Adherence rates were high for most prescribing practices, and attendance of scheduled follow-up was higher than expected. Opportunities to improved adherence to CDC guidelines were identified in prescribing for 3 disease states (human immunodeficiency virus, trichomoniasis, and hepatitis B) and in scheduling of follow-up.